Hongene Biotech, founded in 1998 and headquartered in Shanghai, China, is a global specialist in nucleic acid manufacturing. The company offers a comprehensive range of products and services, including nucleosides, nucleotides, phosphoramidites, oligonucleotide synthesis, and mRNA manufacturing, supporting clients from research through commercial production. With state-of-the-art facilities spanning over 30,000 square feet, Hongene provides end-to-end solutions encompassing process development, analytical development, drug substance manufacturing, and quality control. Hongene maintains a global presence with offices in the U.S., Germany, Japan, and China, and actively collaborates with pharmaceutical, diagnostic, and biotechnology companies worldwide.